The insulin autoimmune syndrome (IAS) as a cause of hypoglycaemia: an update on the pathophysiology, biochemical investigations and diagnosis
The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Insulin autoimmune syndrome (IAS) is considered to be very rare in Caucasians. Understanding its pathophysiology is paramount in (a) appreciating its potential impact on analyses of pancreatic hormones and (b) explaining its highly variable clinical manifestations in non-diabetic, non-acutely ill patients with indeterminate hypoglycaemia. The underlying aetiology of IAS is the presence of variable affinity/avidity endogenous insulin antibodies in significant amounts. The two types of insulin antibodies namely antibodies which bind insulin and/or proinsulin(s) and receptor antibodies (insulin mimetic) will be discussed. Their biochemical and immunological roles in causing hypoglycaemia will be highlighted. Clinical manifestations of IAS can vary from mild and transient to spontaneous, severe and protracted hypoglycaemia necessitating in extreme cases plasmapheresis for glycaemic control. Antibodies of IAS can interfere in pancreatic immunoassay tests causing erroneous and potentially misleading results. Thorough testing for endogenous insulin antibodies must be considered in the investigations of non-diabetic, non-acutely ill patients with indeterminate and/or unexplained hypoglycaemia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cryer, P. E., Axelrod, L., Grossman, A. B., Heller, S. R., Montori, V. M., Seaquist, E. R., & Service, F. J. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1410 · Cited by 1,277 · cited 1×
“Testing for “insulin antibodies” is now included among the first-line tests in the recently published clinical practice guidelines by the American Endocrine Society in 2009 [84] and reiterated in a short note in 2012 [85].”
BackgroundVezzosi, D., Bennet, A., Fauvel, J., & Caron, P. (2007) · European Journal of Endocrinology · doi:10.1530/eje-07-0109 · Cited by 152 · cited 1×
“(2007; on 33 patients) [63] and Guettier et al.”
BackgroundInsulin Autoimmune Syndrome (Hirata Disease): Clinical Features and Epidemiology in Japan
Uchigata, Y., Eguchi, Y., Takayama-Hasumi, S., & Omori, Y. (1994) · Diabetes Research and Clinical Practice · doi:10.1016/0168-8227(94)90040-x · Cited by 127 · cited 1×
“In few patients however, recurrent attacks have subsequently ensued without exposure to any drug prior to their recurrent hypoglycaemic episodes [83].”
BackgroundRecurrent Hypoglycemia from Insulin Autoimmune Syndrome
Wong, S. L., Priestman, A., & Holmes, D. T. (2014) · Journal of General Internal Medicine · doi:10.1007/s11606-013-2588-9 · Cited by 73
Insulin Autoimmune Syndrome (Hirata Disease) in European Caucasians Taking α-Lipoic Acid
Gullo, D., Evans, J. L., Sortino, G., Goldfine, I. D., & Vigneri, R. (2014) · Clinical Endocrinology · doi:10.1111/cen.12334 · Cited by 71
Hypoglycemia due to an insulin binding antibody in a patient with an IgA-κ myeloma.
Halsall, D. J., Mangi, M., Soos, M., Fahie-Wilson, M. N., Wark, G., Mainwaring-Burton, R., & O’Rahilly, S. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0075 · Cited by 56
Gomez Cruz, M. J., Jabbar, M., Saini, N., Eng, D., Crawford, B., Vazquez, D. M., Menon, R., & Chen, M. (2012) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2012.00884.x · Cited by 34
Cited by
Insulin autoimmune syndrome: from diagnosis to clinical management
Censi, S., Mian, C., & Betterle, C. (2018) · Annals of Translational Medicine · doi:10.21037/atm.2018.07.32 · Cited by 152
Cappellani, D., Macchia, E., Falorni, A., & Marchetti, P. (2020) · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · doi:10.2147/dmso.s219438 · Cited by 138
Case 23-2018: a 36-year-old man with episodes of confusion and hypoglycemia
Wexler, D. J., Macias-Konstantopoulos, W., Forcione, D. G., Xiong, L., Cauley, C. E., & Pierce, K. J. (2018) · New England Journal of Medicine · doi:10.1056/nejmcpc1802828 · Cited by 16
Metadata
- Authors
- Ismail, A. A. A.
- Venue
- Clinical Chemistry and Laboratory Medicine (CCLM)
- Publisher
- Walter de Gruyter GmbH
- Published
- 2016-04-12
- Volume
- 54
- Issue
- 11
- Pages
- 1715-1724
- ISSN
- 1434-6621 (ISSN-L)
- 1437-4331
- OpenAlex
- W2342162545
- Cited by
- 100
- References
- 7
- FWCI
- 6.12
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.